Study on the Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors: Traditional Chinese Medicine Combined With Somatostatin Analogues

首页> 外文期刊>Pancreas >Study on the Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors: Traditional Chinese Medicine Combined With Somatostatin Analogues

【24h】

Study on the Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors: Traditional Chinese Medicine Combined With Somatostatin Analogues

机译：晚期胃肠内神经内分泌肿瘤治疗研究：中药联合生长抑素类似物

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Pancreas》 |2020年第3期|共1页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词
入库时间 2022-08-20 05:57:25

相似文献

外文文献
中文文献
专利

1. Study on the Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors: Traditional Chinese Medicine Combined With Somatostatin Analogues [J] . Pancreas . 2020,第3期

机译：晚期胃肠内神经内分泌肿瘤治疗研究：中药联合生长抑素类似物
2. Patient And Nurse Experience Of Using Somatostatin Analogues To Treat Gastroenteropancreatic Neuroendocrine Tumors: Results Of The Somatostatin Treatment Experience Trial (STREET) [J] . Torbj?rn Str?m, Gordana Kozlovacki, Peter Myrenfors, Patient Preference and Adherence . 2019,第S1期

机译：使用生长抑素类似物治疗胃肠道胰腺神经内分泌肿瘤的患者和护士经验：生长抑素治疗经验试验（STREET）的结果
3. Impact of Prior Somatostatin Analogue (SSA) Use on Progression-free Survival (PFS) in Patients With Advanced Nonfunctional Neuroendocrine Tumors (NET) of Lung or Gastrointestinal (GI) Origin: A Secondary Analysis from the RADIANT-4 Study [J] . Buzzoni Roberto, Carnaghi Carlo, Pommier Rodney, Pancreas . 2017,第3期

机译：先前生长抑制素类似物（SSA）对肺癌或胃肠道（GI）原产地（GI）的患者的无进展存活（PFS）的影响：辐射-4研究中的二级分析
4. Effect Report of Radio Frequency Combined with Traditional Chinese Medicine on 390 Malignant Tumor of Middle or Advanced Stage [C] . The 3rd Asian congress on hyperthermic oncology and the 9th Chineses symposium on hyperthermic oncology . 2002

机译：射频联合中药治疗390例中晚期恶性肿瘤的疗效报告
5. Improving Survival Prognostication of Gastroenteropancreatic Neuroendocrine Tumors [D] . Martin, Jacob A. 2017

机译：改善胃肠道胰腺神经内分泌肿瘤的生存预后
6. Somatostatin receptor expression indicates improved prognosis in gastroenteropancreatic neuroendocrine neoplasm and octreotide long-acting release is effective and safe in Chinese patients with advanced gastroenteropancreatic neuroendocrine tumors [O] . Yuhong Wang, Wei Wang, Kaizhou Jin, -1

机译：生长抑素受体的表达表明胃肠道胰腺神经内分泌肿瘤的预后得到改善奥曲肽长效释放在中国晚期胃肠道胰腺神经内分泌肿瘤患者中是安全有效的
7. Somatostatin receptor expression indicates improved prognosis in gastroenteropancreatic neuroendocrine neoplasm, and octreotide long-acting release is effective and safe in Chinese patients with advanced gastroenteropancreatic neuroendocrine tumors [O] . Yuhong Wang, Wei Wang, Kaizhou Jin, 2017

机译：生长抑素受体表达表明，胃肠内科神经内分泌肿瘤的预后改善，奥德雷德雷德长效释放在中国晚期的胃肠细胞神经内分泌肿瘤患者中是有效和安全的

Study on the Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors: Traditional Chinese Medicine Combined With Somatostatin Analogues

著录项

相似文献

相关主题

期刊订阅